Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.41 |
| ▸ | PTAFR | P25105 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6123492 | 1.00 | ACHE (0.41) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL6123488 | 0.96 | ACHE (0.40) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL5947814 | 0.96 | ACHE (0.40) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL6123583 | 0.95 | ACHE (0.39) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL5948377 | 0.92 | ACHE (0.37) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL6123567 | 0.91 | ACHE (0.36) | ACHEPTAFRALDH1A1KDM4EMAPT | |
| SCHEMBL5948257 | 0.91 | ACHE (0.36) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL5947920 | 0.89 | ACHE (0.35) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL5947974 | 0.89 | ACHE (0.35) | ACHEPTAFRALDH1A1KDM4ECYP1A2 | |
| SCHEMBL5948307 | 0.89 | PTAFR (0.36) | ACHEPTAFRALDH1A1KDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173273-B2 | Anthracene derivatives, method for preparation thereof, and organic electronic device using the same | LG CHEM, LTD. (KR) | 2012-05-08 | — | — | US | disclosed |
| US-20100044681-A1 | Novel Anthracene Derivatives, Method for Preparation Thereof, and Organic Electronic Device Using the Same | LG CHEM, LTD. (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044681-A1 | Novel Anthracene Derivatives, Method for Preparation Thereof, and Organic Electronic Device Using the Same | XPOT, TOMM22, TIMM10 | ACHE 420/4885PTAFR 4821/4885ALDH1A1 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.